CASTRATION RESISTANT METASTATIC PROSTATE CANCER
Clinical trials for CASTRATION RESISTANT METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION RESISTANT METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION RESISTANT METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a testosterone boost help fight resistant prostate cancer?
Disease control Recruiting nowThis study is for men with a type of advanced prostate cancer that no longer responds to standard hormone therapy. It compares two treatments: taking the drug enzalutamide alone versus taking it along with high-dose testosterone in cycles. The goal is to see if the combination ca…
Matched conditions: CASTRATION RESISTANT METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New radioactive drug takes aim at Hard-to-Treat prostate cancer
Disease control Recruiting nowThis early-stage trial tests a new drug that delivers radiation directly to prostate cancer cells. It is for men with metastatic castration-resistant prostate cancer, a form that has stopped responding to hormone therapy. The study will check for side effects and see if the drug …
Matched conditions: CASTRATION RESISTANT METASTATIC PROSTATE CANCER
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New study aims to predict which prostate cancer patients benefit from Lu-PSMA therapy
Knowledge-focused Recruiting nowThis study is looking for genetic clues in tumor tissue that could predict whether Lu-PSMA treatment will be effective for men with advanced, castration-resistant prostate cancer. About 120 men who have already tried other treatments will provide tumor samples for analysis. The g…
Matched conditions: CASTRATION RESISTANT METASTATIC PROSTATE CANCER
Phase: NA • Sponsor: Centre Jean Perrin • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC